Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pathnova Laboratories
Singapore, Singapore
- Ownership
- Private
- Employees
- ~5
- Development stage
- Other
01
Overview
Pathnova Laboratories achieved national recognition for large-scale COVID-19 PCR testing (over 120,000 tests analyzed for the Ministry of Health) with rapid turnaround (results in 36 minutes) and has developed scalable serological diagnostics for nasopharyngeal cancer and autoimmune diseases using machine learning. The lab operates ISO 13485 and CAP-accredited facilities with HSA-approved in vitro diagnostic kits[1][3][5].
- Therapeutic areas
- OncologyInfectious DiseasesImmunology
- Modalities
- Diagnostic testSerological test
- Industry
- Molecular Diagnostics
02
Partnerships
NTU Lee Kong Chian School of MedicineTemasek Life Sciences Accelerator
Beyond the preview
Go deeper on Pathnova Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pathnova Laboratories.